Masashi Taki

Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A

Midori Shima, Hideji Hanabusa, Masashi Taki et al. · New England Journal of Medicine · 2016 · 449 citations · Full text

A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

Midori Shima, Keiji Nogami, Sayaka Nagami et al. · Haemophilia · 2019 · 148 citations · Full text

Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors

Midori Shima, Hideji Hanabusa, Masashi Taki et al. · Blood Advances · 2017 · 122 citations · Full text

Phase 1/2, Thrombosis, Translational Medicine +14

Yersinia pseudotuberculosis infection in children, resembling Izumi fever and Kawasaki syndrome

Koichiro Sato, Kazunobu Ouchi, Masashi Taki · The Pediatric Infectious Disease Journal · 1983 · 103 citations

Kawasaki Syndrome, Yersinia Isolates, Typhoid Fever +14

The prevalence of neutralizing antibodies against adeno‐associated virus capsids is reduced in young Japanese individuals

Jun Mimuro, Hiroaki Mizukami, Midori Shima et al. · Journal of Medical Virology · 2013 · 73 citations